147 related articles for article (PubMed ID: 22965642)
1. Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area.
Wang X; Levin AM; Smolinski SE; Vigneau FD; Levin NK; Tainsky MA
Am J Med Genet A; 2012 Dec; 158A(12):3061-4. PubMed ID: 22965642
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of breast cancer in women with NF1.
Madanikia SA; Bergner A; Ye X; Blakeley JO
Am J Med Genet A; 2012 Dec; 158A(12):3056-60. PubMed ID: 23165953
[TBL] [Abstract][Full Text] [Related]
3. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.
Sharif S; Moran A; Huson SM; Iddenden R; Shenton A; Howard E; Evans DG
J Med Genet; 2007 Aug; 44(8):481-4. PubMed ID: 17369502
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
[TBL] [Abstract][Full Text] [Related]
7. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
8. Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer.
Campos B; Balmaña J; Gardenyes J; Valenzuela I; Abad O; Fàbregas P; Volpini V; Díez O
Breast Cancer Res Treat; 2013 Jun; 139(2):597-602. PubMed ID: 23624750
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Li CI; Anderson BO; Daling JR; Moe RE
JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
[TBL] [Abstract][Full Text] [Related]
10. Melanoma in individuals with neurofibromatosis type 1: a retrospective study.
Zhang M; Bhat T; Gutmann DH; Johnson KJ
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045143
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
12. Are we ready for targeted early breast cancer detection strategies in women with NF1 aged 30-49 years?
Evans DG
Am J Med Genet A; 2012 Dec; 158A(12):3054-5. PubMed ID: 22987630
[No Abstract] [Full Text] [Related]
13. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in the incidence of in situ and invasive breast cancer in the Detroit metropolitan area (1975-1988).
Simon MS; Lemanne D; Schwartz AG; Martino S; Swanson GM
Cancer; 1993 Feb; 71(3):769-74. PubMed ID: 8431859
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
16. The severity of breast cancer at diagnosis: a comparison of age and extent of disease in black and white women.
Satariano WA; Belle SH; Swanson GM
Am J Public Health; 1986 Jul; 76(7):779-82. PubMed ID: 3717463
[TBL] [Abstract][Full Text] [Related]
17. Breast density in NF1 women: a retrospective study.
De Santis R; Cagnoli G; Rinaldi B; Consonni D; Conti B; Eoli M; Liguori A; Cosentino M; Carrafiello G; Garrone O; Giroda M; Cesaretti C; Sfondrini MS; Gambini D; Natacci F
Fam Cancer; 2024 Mar; 23(1):35-40. PubMed ID: 38270845
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancy in scleroderma: a population-based cohort study.
Chatterjee S; Dombi GW; Severson RK; Mayes MD
Arthritis Rheum; 2005 Aug; 52(8):2415-24. PubMed ID: 16052585
[TBL] [Abstract][Full Text] [Related]
19. Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.
Suarez-Kelly LP; Yu L; Kline D; Schneider EB; Agnese DM; Carson WE
Hered Cancer Clin Pract; 2019; 17():12. PubMed ID: 30962859
[TBL] [Abstract][Full Text] [Related]
20. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
